SCHEMBL13638644

SCHEMBL13638644

COc1ccc2c(=O)c(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(C)s4)cc3C)n[nH]c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.42
NLRP3 Q96P20 2/20 0.39
ITK Q08881 4/20 0.38
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
ROCK1 Q13464 2/20 0.37
CHEK1 O14757 1/20 0.36
TNIK Q9UKE5 2/20 0.36
MAP2K4 P45985 1/20 0.35
LRRK2 Q5S007 1/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923260 0.92 KIT (0.43) FBP1NLRP3ITKPRKAB2PRKAG1
SCHEMBL9922391 0.89 ROCK1 (0.45) FBP1NLRP3ITKROCK1CHEK1
SCHEMBL14088508 0.85 MEN1 (0.42) FBP1NLRP3ITKPRKAB2PRKAG1
SCHEMBL12161716 0.84 P2RY12 (0.44) FBP1NLRP3ITKPRKAB2PRKAG1
SCHEMBL12161694 0.81 ROCK1 (0.44) FBP1NLRP3PRKAB2PRKAG1PRKAA2
SCHEMBL14228352 0.80 CA12 (0.39) ITKROCK1NPC1RAB9AMAOB
SCHEMBL9922623 0.78 MEN1 (0.42) FBP1ITKROCK1CHEK1MAP2K4
SCHEMBL9922220 0.76 MAPT (0.40) FBP1NLRP3NPC1MAPTRAB9A
SCHEMBL13633811 0.76 P2RY12 (0.42) FBP1ITKLRRK2MAPTMEN1
SCHEMBL9923253 0.75 MAPT (0.41) FBP1NLRP3PRKAB2PRKAG1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed